News

Procede Software's Growth Investment Fuels New Innovations

Procede Software's Growth Investment Fuels New Innovations

Strategic Growth Investment for Procede Software

Investment positions Procede Software to accelerate innovation and expand its leadership in the commercial vehicle ecosystem

Procede Software, a leading provider of enterprise-level dealer management systems for the commercial vehicle industry, recently announced a strategic majority investment from Rubicon Technology Partners, a notable private equity firm dedicated to enhancing enterprise software companies. This new partnership is set to bolster Procede's ability to innovate and solidify its presence in the commercial vehicle space.

With over two decades of experience, Procede Software offers the pioneering DMS platform known as Excede, renowned for its reliability and comprehensive integration capabilities across dealership departments. These advantages make it a trusted choice for dealerships across North America, where Procede's solutions empower businesses to boost operational efficiency and enhance decision-making processes. Recently, Procede introduced Procede Intelligence, which adds advanced AI capabilities to its current offerings.

“This investment signifies a substantial milestone for Procede,” stated Larry Kettler, CEO and Chairman of Procede Software. “From the very beginning, our philosophy has been centered on listening to our customers, investing in innovation, and delivering significant value. With Rubicon’s extensive experience in the industry, we can accelerate our mission by enhancing our product suite and developing more integrations within the commercial vehicle ecosystem.”

Ben Falloon, Principal at Rubicon, expressed enthusiasm about the partnership, noting, “Procede Software aligns perfectly with the innovative product leadership and customer-focused culture that we prioritize at Rubicon. We are thrilled to join forces with Larry and the entire Procede team as they embark on this exciting phase of growth and innovation.”

About Procede Software

Founded in 2001, Procede Software has established itself as a prominent provider of enterprise-level Dealer Management Solutions, primarily catering to the heavy-duty commercial vehicle sector and adjoining markets. The company’s Excede platform is trusted by leading dealerships in the United States, Canada, and Australia for its robust features, reliability, and seamless integration with original equipment manufacturers (OEMs). With advanced features built on Microsoft SQL Server, combined with emerging AI capabilities and modern workflows, Excede provides the data-driven insights necessary for dealerships to maintain their competitive edge.

About Rubicon Technology Partners

Rubicon Technology Partners is a middle-market private equity firm dedicated to investing in enterprise software companies boasting innovative products and strong management teams. Established in 2012 and managing over $4 billion in assets, Rubicon employs a hands-on approach to facilitate the growth and scalability of portfolio companies, utilizing best practices and operational expertise acquired through numerous acquisitions.

Future Prospects of Procede Software

As Procede Software moves forward with this investment from Rubicon, the focus will be on leveraging the partnership to enhance product offerings and integration capabilities. Customers can anticipate advancements in the Excede platform, as Procede aims to not only maintain but expand its influence in the market. This strategic move is poised to unlock new opportunities for growth and innovation, ultimately benefiting the dealership customers who rely on Procede's systems.

Conclusion: A Bright Future Ahead

In summation, Procede Software's decision to partner with Rubicon Technology Partners marks a significant step towards enhancing its operational capabilities and continuing its legacy of serving the commercial vehicle industry. With a clear vision for the future and a commitment to innovation, Procede is poised for substantial growth. This partnership is not just about investment; it’s about empowering the next generation of solutions that will redefine how dealerships operate and thrive in a competitive landscape.

Frequently Asked Questions

What is the significance of the investment for Procede Software?

The investment from Rubicon Technology Partners enables Procede Software to amplify its innovation, enhance its product offerings, and strengthen its presence in the commercial vehicle industry.

What features does Procede Software's Excede platform offer?

Excede offers comprehensive functionality for dealerships, providing reliable integrations, operational efficiencies, and advanced capabilities like AI to support decision-making.

Who is the primary investor in Procede Software?

Rubicon Technology Partners is the primary investor, known for its focus on scaling enterprise software companies.

How long has Procede Software been in operation?

Procede Software has been operating since 2001, establishing itself as a key player in dealer management solutions over the years.

What is the strategic objective of Rubicon Technology Partners?

Rubicon's strategic objective is to invest in and collaborate with companies to drive innovation, scalability, and operational excellence in software development.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 87

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 206

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 63

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 119

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 177

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Stephen A. Smith Calls for Corporate Support of HBCUs

Updated Category News Views 38

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 104

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 46

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Gentex Shares Tumble Amid Legal Investigation Concerns

Updated Category News Views 10

Gentex's Financial Outlook Takes a Hit Well, here we are again, catching another corporate hiccup. Gentex Corporation, or as ticker hounds know it, NASDAQ:GNTX, just pulled the rug out from its investors by chopping the top off its 2026 revenue guidance. Dropping to a floor it once considered a ceiling, $2.65 billion is now the most optimistic number they're pitching. No...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 198

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading

Top 5 Most Recently Viewed Articles

MiMedx Group Q4 Earnings: Impressive Beat Raises Eyebrows

Updated Category News Views 262

What a Turnaround! Numbers don’t lie, right? Well, take a look at MiMedx Group (NASDAQ:MDXG) and you see a company that’s done some real transformation. Their Q4 report came out on February 25, 2026, and it’s hard not to be impressed. They smashed the earnings estimate—by a whopping 40%. That’s no small feat in this market, especially when you look at the EPS...

Continue Reading
Intuitive Machines Sets Financial Results Conference Call Date

Updated Category News Views 132

Intuitive Machines Schedules Conference Call for Financial Results Intuitive Machines, Inc. (Nasdaq: LUNR) has made an important announcement regarding its upcoming financial results. The company is set to release its fourth quarter and full-year financial outcomes, providing an in-depth look at its performance for 2024. This announcement will be made on a specific date...

Continue Reading
OSB Group PLC: Insights into the Latest Block Listing Return

Updated Category News Views 326

Understanding OSB Group PLC's Block Listing Return In the ever-evolving landscape of financial markets, regular disclosures play a pivotal role in maintaining transparency. Here, we delve into the latest block listing return from OSB Group PLC, outlining crucial details in a clear and concise manner. Key Details of the Block Listing Return It's essential for stakeholders...

Continue Reading
Gemini Expands its Offerings with Tokenized U.S. Equities

Updated Category News Views 342

Gemini Launches Tokenized U.S. Equities In an exciting development for European investors, Gemini has expanded its offerings by facilitating the trading of tokenized U.S. equities. This marks a significant shift in providing easier access to international investment opportunities. Initially launched for its user base in Europe, Gemini aims to create a seamless experience...

Continue Reading
Vivian Health Welcomes New CEO Bill Kong for Future Growth

Updated Category News Views 125

Vivian Health's New Era with CEO Bill Kong Vivian Health, a prominent player in the healthcare jobs marketplace, is transitioning into a new chapter under the leadership of Bill Kong, who has been appointed as the CEO. This strategic move follows the remarkable success achieved by Parth Bhakta, co-founder and outgoing CEO, who now assumes the role of Executive Chairman....

Continue Reading